EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Influence of state-of-the-art laboratory techniques on the phenotyping of women with polycystic ovary syndrome in the clinical setting

M Luque-Ramírez, M Á Martínez-García, M Insenser, E Fernández-Durán, A Quintero-Tobar, T Fiers, J-M Kaufman, A M García-Cano, M Rosillo Coronado, L Nattero-Chávez, H F Escobar-Morreale

Journal of Endocrinological Investigation · 2024

DOI: 10.1007/s40618-024-02416-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Endocrinological Investigation, 2024. Verfasst von M Luque-Ramírez und 10 weiteren Autor:innen. Beteiligte Einrichtung: Diabetes, Obesity, and Human Reproduction Research Group, Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (…. Hauptthemen laut MEDLINE: Polycystic Ovary Syndrome, Anti-Mullerian Hormone, Hyperandrogenism. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto de Salud Carlos III, Universidad de Alcalá.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Evidence-based guidelines for the management of polycystic ovary syndrome (PCOS) recommend clinical laboratories use liquid chromatography-tandem mass spectrometry (LC–MS/MS) for diagnosing biochemical hyperandrogenism. However, automated immunoassays are still mostly used in routine laboratories worldwide. Another hurdle for PCOS phenotyping in the clinical setting is ultrasound assessment of polycystic ovarian morphology. We address the impact of using state-of-the-art (LC–MS/MS) and of an anti-müllerian hormone (AMH) assay on the diagnosis of PCOS in routine practice.

Methods

In a cross-sectional study, we included 359 premenopausal women consecutively evaluated because of symptoms of functional androgen excess or hyperandrogenemia, and finally diagnosed with PCOS. Patients were submitted to routine phenotyping based on serum androgen measurements by immunoassays and an ovarian ultrasound when necessary. Samples of all patients were also assayed by LC–MS/MS for hyperandrogenemia and for circulating AMH.

Results

The observed agreement between immunoassays and LC–MS/MS in identifying hyperandrogenemia was poor [78.0%; k(95%CI): 0.366 (0.283;0.449)]. The observed agreement between ultrasound and increased AMH was 27.3% [(95%CI): 0.060 (0.005; 0.115)]. Using LC–MS/MS changed PCOS phenotypes in 60(15.8%) patients. Fifty-two (18.3%) individuals with hyperandrogenemia by routine immunoassays no longer presented with androgen excess by LC–MS/MS. Overall diagnostic agreement between routine assessment using immunoassays and ultrasound and that derived from LC–MS/MS and the addition of AMH to US was moderate [weighted κ (linear weights): 0.512 (0.416;0.608)].

Conclusions

Immunoassays used in routine practice are unacceptably inaccurate for phenotyping women with PCOS. Our data cast some doubts upon the interchangeability of serum AMH and ultrasound examination for the diagnosis of PCOS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Polycystic Ovary SyndromeAnti-Mullerian HormoneHyperandrogenismHumansFemaleAdultCross-Sectional StudiesPhenotypeTandem Mass SpectrometryChromatography, LiquidYoung AdultImmunoassayUltrasonography

Stichwörter der Autor:innen

AndrogensDiagnosis of endocrine diseaseReproductive endocrinology Ovary

Substanzen

Anti-Mullerian Hormone

Autor:innen und Institutionen

  • Diabetes, Obesity, and Human Reproduction Research Group, Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM) from Instituto de Salud Carlos III, Instituto Ramón y Cajal…
  • Department of Endocrinology and Nutrition, Hospital Universitario Ramón y Cajal, Carretera de Colmenar Viejo, KM 9.1, 28034, Madrid, Spain. manuel.luque@salud.madrid.org.
  • Laboratory for Hormonology, Department of Endocrinology, Ghent University Hospital, 9000, Ghent, Belgium.
  • Department of Biochemistry, Hospital Universitario Ramón y Cajal, Madrid, Spain.
  • Department of Endocrinology and Nutrition, Hospital Universitario Ramón y Cajal, Carretera de Colmenar Viejo, KM 9.1, 28034, Madrid, Spain.

Förderung

  • Instituto de Salud Carlos III
  • Universidad de Alcalá

Zitieren

APA

Luque-Ramírez, M., Martínez-García, M. Á., Insenser, M., Fernández-Durán, E., Quintero-Tobar, A., Fiers, T., Kaufman, J. M., García-Cano, A. M., Rosillo Coronado, M., Nattero-Chávez, L., & Escobar-Morreale, H. F. (2024). Influence of state-of-the-art laboratory techniques on the phenotyping of women with polycystic ovary syndrome in the clinical setting. Journal of Endocrinological Investigation. https://doi.org/10.1007/s40618-024-02416-0

Vancouver

Luque-Ramírez M, Martínez-García MÁ, Insenser M, Fernández-Durán E, Quintero-Tobar A, Fiers T, et al. Influence of state-of-the-art laboratory techniques on the phenotyping of women with polycystic ovary syndrome in the clinical setting. Journal of Endocrinological Investigation. 2024. doi:10.1007/s40618-024-02416-0

BibTeX
@article{LuqueRamrez2024,
  author = {Luque-Ramírez, M and Martínez-García, M Á and Insenser, M and Fernández-Durán, E and Quintero-Tobar, A and Fiers, T and Kaufman, J-M and García-Cano, A M and Rosillo Coronado, M and Nattero-Chávez, L and Escobar-Morreale, H F},
  title = {Influence of state-of-the-art laboratory techniques on the phenotyping of women with polycystic ovary syndrome in the clinical setting},
  journal = {Journal of Endocrinological Investigation},
  year = {2024},
  doi = {10.1007/s40618-024-02416-0}
}
Kostenlos starten →